GlassScriptPhysician profile
Mary A Dougal
NPI 1740358886
$829.19
in general payments reported to CMS, 2019-2025
15 companies · $131 in 2025
The $131 reported for 2025 was less than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $130 · 2020: $65.51 · 2021: $161 · 2022: $137 · 2023: $205 · 2025: $131.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $337.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $336.83 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $123.25 | 2020-2025 | Tryptyr |
| Sun Pharmaceutical Industries INC. | $120.05 | 2019-2023 | Cequa |
| Novartis Pharmaceuticals Corporation | $116.35 | 2020-2022 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $99.97 | 2019 | |
| Bausch & Lomb Americas INC. | $97.81 | 2023 | Miebo |
| Aerie Pharmaceuticals, INC. | $46.69 | 2021 | |
| Lkc Technologies, INC. | $45.97 | 2025 | |
| Harrow Eye, LLC | $40.32 | 2025 | Vevye |
| Thea Pharma INC. | $40.16 | 2023-2025 | Iyuzeh |
| Akorn Operating Company LLC | $19.34 | 2021 | |
| Beaver-Visitec International, INC. | $18.99 | 2023 | |
| Allergan, INC. | $17.04 | 2021 | |
| Shire North American Group INC | $15.00 | 2019 | |
| Biotissue Holdings INC. | $14.23 | 2021 | |
| Tearlab Corp | $14.02 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mary Dougal listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.